Domperidona: la Agencia Europea del Medicamento ( EMA) recomienda restringir su uso.

Informe de la EMA

PRAC recommends restricting use of domperidone: Benefits still considered to outweigh risks when given short-term and in low doses to treat nausea or vomiting. EMA, 07/03/2014